Jair M. Mendoza

Jair M. Mendoza

Nephrology

1450 Northwest 10th Avenue
Miami, FL 33136

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis.

Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis.

Journal: Lupus

Published: August 05, 2026

Trends of preemptive kidney transplantation in lupus compared to other primary diseases leading to end stage kidney disease in the United States of America.

Trends of preemptive kidney transplantation in lupus compared to other primary diseases leading to end stage kidney disease in the United States of America.

Journal: Lupus

Published: May 20, 2025

Finerenone in People with CKD, Type 2 Diabetes, and History of Nephrectomy.

Finerenone in People with CKD, Type 2 Diabetes, and History of Nephrectomy.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: May 01, 2025

Relationships among Non-Neoplastic Histopathological Features, Kidney Function, Proteinuria, and Other Clinical Factors in Patients Undergoing Nephrectomy.

Relationships among Non-Neoplastic Histopathological Features, Kidney Function, Proteinuria, and Other Clinical Factors in Patients Undergoing Nephrectomy.

Journal: Glomerular diseases

Published: June 30, 2023

National Trends in Glucagon Prescriptions Among U.S. Adults With Diabetes and End-Stage Kidney Disease Treated by Dialysis: 2013-2017.

National Trends in Glucagon Prescriptions Among U.S. Adults With Diabetes and End-Stage Kidney Disease Treated by Dialysis: 2013-2017.

Journal: Diabetes care

Published: March 29, 2023

One-year all-cause mortality in hospitalized patients with COVID-19 and end-stage renal disease undergoing hemodialysis.

One-year all-cause mortality in hospitalized patients with COVID-19 and end-stage renal disease undergoing hemodialysis.

Journal: Clinical nephrology

Published: December 15, 2022

COVID-19 in a patient with end-stage renal disease on chronic in-center hemodialysis after evidence of SARS-CoV-2 IgG antibodies. Reinfection or inaccuracy of antibody testing.

COVID-19 in a patient with end-stage renal disease on chronic in-center hemodialysis after evidence of SARS-CoV-2 IgG antibodies. Reinfection or inaccuracy of antibody testing.

Journal: IDCases

Published: August 10, 2020

Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.

Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.

Journal: Kidney international

Published: May 26, 2016

Diuretics, Limited Ultrafiltration, and Residual Renal Function in Incident Hemodialysis Patients: A Case Series.

Diuretics, Limited Ultrafiltration, and Residual Renal Function in Incident Hemodialysis Patients: A Case Series.

Journal: Seminars in dialysis

Published: May 07, 2016

Dialysate Sodium: Choosing the Optimal Hemodialysis Bath.

Dialysate Sodium: Choosing the Optimal Hemodialysis Bath.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: November 22, 2014

Comparison of mortality of ESRD patients with lupus by initial dialysis modality.

Comparison of mortality of ESRD patients with lupus by initial dialysis modality.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: September 06, 2014

Can your hunch get this punch?

Can your hunch get this punch?

Journal: Clinical kidney journal

Published: May 15, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026